Herpes zoster as a risk factor for stroke and TIA: A retrospective cohort study in the UK

Neurology

Volumn 83, Issue 2, 2014, Pages

  Breuer, Judith ^a   Pacou, Maud ^c   Gautier, Aline ^c   Brown, Martin M ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

ADULT; ARTICLE; BODY MASS; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HERPES ZOSTER; HUMAN; HYPERTENSION; INTERMITTENT CLAUDICATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OBESITY; POSITIONAL VERTIGO; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SMOKING; TRANSIENT ISCHEMIC ATTACK; UNITED KINGDOM; VALVULAR HEART DISEASE; VARICELLA ZOSTER VIRUS; AGED; COMPLICATION; FACTUAL DATABASE; ISCHEMIC ATTACK, TRANSIENT; KAPLAN MEIER METHOD; MIDDLE AGED; MYOCARDIAL INFARCTION; PREVALENCE; PROPORTIONAL HAZARDS MODEL; STATISTICAL BIAS; STROKE; SURVIVAL;

ADULT; AGED; BIAS (EPIDEMIOLOGY); COHORT STUDIES; DATABASES, FACTUAL; FEMALE; GREAT BRITAIN; HERPES ZOSTER; HUMANS; ISCHEMIC ATTACK, TRANSIENT; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; SURVIVAL ANALYSIS;

EID: 84904022617     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000584     Document Type: Article

References (35)

1. Zuckerman AJ, Banatvala JE, Schoub BD, Griffiths PD, Mortimer P, Breuer J. Varicella zoster. In: Zuckerman AJ, Banatvala JE, Schoub BD, Griffiths PD, Mortimer P, editors. Principles and Practice of Clinical Virology, 6th ed. Chichester: John Wiley & Sons; 2009: 133-160.
2. Gilden D, Cohrs RJ, Mahalingam R, Nagel MA. Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet Neurol 2009;8: 731-740.
3. Gilden DH, Lipton HL, Wolf JS, et al. Two patients with unusual forms of varicella-zoster virus vasculopathy. N Engl J Med 2002;347: 1500-1503.
4. Kang JH, Ho JD, Chen YH, Lin HC. Increased risk of stroke after a herpes zoster attack: a population-based follow-up study. Stroke 2009;40: 3443-3448.
5. Lin HC, Chien CW, Ho JD. Herpes zoster ophthalmicus and the risk of stroke: a population-based follow-up study. Neurology 2010;74: 792-797.
6. Booth N. What are the read codes? Health Libr Rev 1994; 11: 177-182.
7. Cegedim Strategic Data. Available at: http://csdmruk. cegedim.com/our-data/our-data.shtml. Accessed July 9, 2013.
8. Heskel NS, Hanifin JM. "Recurrent herpes zoster": an unproved entity? J Am Acad Dermatol 1984;10: 486-490.
9. Koh MJ, Seah PP, Teo RY. Zosteriform herpes simplex. Singapore Med J 2008;49: e59-e60.
10. Fisher M. Stroke and TIA: epidemiology, risk factors, and the need for early intervention. Am J Manag Care 2008; 14: S204-S211.
11. Rodgers H, Greenaway J, Davies T, Wood R, Steen N, Thomson R. Risk factors for first-ever stroke in older people in the North East of England: a population-based study. Stroke 2004;35: 7-11.
12. Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med 1965;58: 9-20.
13. Gauthier A, Breuer J, Carrington D, Martin M, Remy V. Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom. Epidemiol Infect 2009; 137: 38-47.
14. Bots ML, van der Wilk EC, Koudstaal PJ, Hofman A, Grobbee DE. Transient neurological attacks in the general population: prevalence, risk factors, and clinical relevance. Stroke 1997;28: 768-773.
15. Lee S, Shafe AC, Cowie MR. UK stroke incidence, mortality and cardiovascular risk management 1999-2008: time-trend analysis from the General Practice Research Database. BMJ Open 2011;1: e000269.
16. Department of Health. Putting Prevention First: Vascular Checks -Risk Assessment and Management. Accessed PPD, 2010. London: Department of Health; 2008.
17. Miravet E, Danchaivijitr N, Basu H, Saunders DE, Ganesan V. Clinical and radiological features of childhood cerebral infarction following varicella zoster virus infection. Dev Med Child Neurol 2007;49: 417-422.
18. Sebire G, Meyer L, Chabrier S. Varicella as a risk factor for cerebral infarction in childhood: a case-control study. Ann Neurol 1999;45: 679-680.
19. Askalan R, Laughlin S, Mayank S, et al. Chickenpox and stroke in childhood: a study of frequency and causation. Stroke 2001;32: 1257-1262.
20. Sreenivasan N, Basit S, Wohlfahrt J, et al. The short-and long-term risk of stroke after herpes zoster: a nationwide population-based cohort study. PLoS One 2013;8: e69156.
21. Nagel MA, Traktinskiy I, Azarkh Y, et al. Varicella zoster virus vasculopathy: analysis of virus-infected arteries. Neurology 2011;77: 364-370.
22. Kleinschmidt-DeMasters BK, Gilden DH. The expanding spectrum of herpesvirus infections of the nervous system. Brain Pathol 2001;11: 440-451.
23. Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 2004;351: 2611-2618.
24. Mehta SK, Cohrs RJ, Forghani B, Zerbe G, Gilden DH, Pierson DL. Stress-induced subclinical reactivation of varicella zoster virus in astronauts. J Med Virol 2004;72: 174-179.
25. Cohrs RJ, Mehta SK, Schmid DS, Gilden DH, Pierson DL. Asymptomatic reactivation and shed of infectious varicella zoster virus in astronauts. J Med Virol 2008; 80: 1116-1122.
26. Gilden D, Nagel MA, Cohrs RJ. Persistence of varicella zoster virus DNA in saliva after herpes zoster. J Infect Dis 2012;205: 1178.
27. Papaevangelou V, Quinlivan M, Lockwood J, et al. Subclinical VZV reactivation in immunocompetent children hospitalized in the ICU associated with prolonged fever duration. Clin Microbiol Infect 2013;19: E245-E251.
28. Mahalingam R, Messaoudi I, Gilden D. Simian varicella virus pathogenesis. Curr Top Microbiol Immunol 2010; 342: 309-321.
29. Mahalingam R, Traina-Dorge V, Wellish M, et al. Latent simian varicella virus reactivates in monkeys treated with tacrolimus with or without exposure to irradiation. J Neurovirol 2010;16: 342-354.
30. Nagel MA, Traktinskiy I, Choe A, Rempel A, Gilden D. Varicella-zoster virus expression in the cerebral arteries of diabetic subjects. Arch Neurol 2012;69: 142-144.
31. Heymann AD, Chodick G, Karpati T, et al. Diabetes as a risk factor for herpes zoster infection: results of a population-based study in Israel. Infection 2008;36: 226-230.
32. Mahalingam R, Wellish M, Wolf W, et al. Latent varicella-zoster viral DNA in human trigeminal and thoracic ganglia. N Engl J Med 1990;323: 627-631.
33. Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc 2007;82: 1341-1349.
34. Quinlivan ML, Ayres KL, Kelly PJ, et al. Persistence of varicella-zoster virus viraemia in patients with herpes zoster. J Clin Virol 2011;50: 130-135.
35. Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005;352: 2271-2284.